Gold nanoparticles are new kinds of nanomaterials. Their large surface-to-volume ratio, stability, excellent biocompatibility, low toxicity and functionality make them very attractive for biomedical applications. Therefore we have analyzed how dendronized gold nanoparticles interact with human alpha-1-microglobulin. This is a glycoprotein of ∼30kDa present in blood plasma and some tissues of the human body. Comparing 3 nanoparticles with different dendronization, we conclude that the effect of a nanoparticle on the structure of alpha-1-microglobulin significantly decreased with second and third generations dendrons as a result of less exposure of the metal cores in the nanoparticles. These interactions indicate weak changes in the immunochemical properties of the protein, whereas the dendron coating had no effect. Thus, dendronization of gold nanoparticles helps to modify their binding properties by shielding them from interactions with plasma proteins.
1 July 2019 in Colloids and Surfaces B: Biointerfaces
Dendrimers are hyperbranched polymers for delivery of therapeutic genetic material to cancer cells. The fine tuning chemical modifications of dendrimers allow for the modification of the composition. The architecture and the properties of dendrimers are key factors to improve their in vitro and in vivo properties such as biocompatibility with cells and tissues and their pharmacokinetic/pharmacodynamic behavior. The side effects of dendrimers on structure and function of proteins is an important question that must be addressed. We herein describe the effect of newly synthesized piperidine-based cationic phosphorous dendrimers of 2 generations and commercial cationic, neutral and anionic poly(amidoamine) (PAMAM) dendrimers of 4th generation on immunochemical properties of 2 serum proteins: human serum albumin (HSA) and alpha-1-microglobulin (A1M). Both can bind and transfer ligands in blood, including hormones, fatty acids, toxins and drugs, and have immunoreactivity properties. Comparing the effects of piperidinium-terminated phosphorus and cationic, neutral and anionic PAMAM dendrimers on HSA and A1M, we conclude that, in the case of equimolar complexes, these dendrimers had no significant effect on immunoreactivity of proteins. In contrast, the formation of complexes in which a protein is fully bound to dendrimers leads to partial (1.2-2.3 times) reduction in protein immunoreactivity. The most important fact is that dendrimer-induced change in immunoreactivity of proteins is not complete, even if the protein is entirely bound by dendrimers. This means that the application of dendrimers in vivo will not totally hamper the immunoreactivity of these proteins and antibodies.
Drug delivery by dendron-based nanoparticles is widely studied due to their ability to encapsulate or bind different ligands. For medical purposes, it is necessary (even if not sufficient) for these nanostructures to be compatible with blood. We studied the interaction of amphiphilic dendrons with blood samples from healthy volunteers using standard laboratory methods and rheological measurements. We did not observe clinically relevant abnormalities, but we found a concentration-dependent increase in whole blood viscosity, higher in males, presumably due to the formation of aggregates. To characterize the nature of the interactions among blood components and dendrons, we performed experiments on the liposomes and exosomes as models of biological membranes. Based on results obtained using diverse biophysical methods, we conclude that the interactions were of electrostatic nature. Overall, we have confirmed a concentration-dependent effect of dendrons on membrane systems, while the effect of generation was ambiguous. At higher dendron concentrations, the structure of membranes became disturbed, and membranes were prone to forming bigger aggregates, as visualized by SEM. This might have implications for blood flow disturbances when used in vivo. We propose to introduce blood viscosity measurements in early stages of investigation as they can help to optimize drug-like properties of potential drug carriers.
Дендримеры - это гиперразветвленные полимеры, принадлежащие к классу наноматериалов. Данные наноструктуры и их производные (дендроны или дендронизированные наночастицы) представляют собой мультитаргетные носители, концевые группы которых можно модифицировать для достижения различных задач, в частности таких, как повышение биосовместимости и стабильности, контролируемое высвобождение активных веществ. Расширение сферы использования дендримеров и дендример-подобных структур в биологии и медицине требует понимания основных механизмов их взаимодействия с белками - одними из основных компонентов биологических систем. В зависимости от размера, поверхностного заряда, структуры и жесткости ветвей дендримеров их взаимодействие с белками может сильно различаться. В частности, могут иметь место как электростатические взаимодействия, возникающие из-за наличия у дендримеров и белков поверхностного заряда, так и гидрофобные, за счет соответствующих полостей в структуре дендримеров. Возможно образование водородных связей. Все эти взаимодействия так или иначе могут влиять на структуру и функции белков. В данном обзоре освещены вопросы механизмов взаимодействия дендримеров и дендронизированных наночастиц с основными белковыми макромолекулами. Рассмотрено влияние наночастиц на вторичную структуру, конформацию, динамику и функциональную активность белков. Описаны различные модели дендример-белковых взаимодействий.